High expression of BTN3A1 is associated with clinical and immunological characteristics and predicts a poor prognosis in advanced human gliomas
Article in Frontiers in Immunology (May 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Heterogeneity and molecular landscape of melanoma: implications for targeted therapy
Article in Molecular Biomedicine (May 2024)
H-VISTA Immunohistochemistry Score Is Associated with Advanced Stages in Cutaneous and Ocular Melanoma
Article in International Journal of Molecular Sciences (April 2024)